Arcus Biosciences, with its intriguing cancer pipeline and big shot CEO, has been a VC favorite since its inception in 2015. Now, Google’s venture arm is backing the Bay Area startup in a new $107 million round, bringing the company’s total haul to a quarter billion in startup capital in two years. The latest infusion of cash was led by…